2022年

Nozuma S, Matsuura E, Tashiro Y, Nagata R, Ando M, Hiramatsu Y, Higuchi Y, Sakiyama Y, Hashiguchi A, Michizono K, Higashi K, Matsuzaki T, Kodama D, Tanaka M, Yamano Y, Moritoyo T, Kubota R, Takashima H.
Efficacy of l-Arginine Treatment in Patients with HTLV-1-Associated Neurological Disease.
Ann Clin Transl Neurol, 2022 in press.🆕

Komine Y, Shimizu T, Akiyama H, Hagiwara Y, Fukano T, Kuwata C, Hasegawa Y, and Yamano Y.
The Usefulness of Heart Rate Variability Spectral Analysis in Detecting Covert Atrial Fibrillation Among Patients with Cryptogenic Stroke.
St. Marianna Med. J., 2022 in press.🆕

Kaburagi K, Shimizu T, Hagiwara Y, Fukano T, Shibata S, Hoshino M, Sasaki N, Akiyama H, Hasegawa Y, Yamano Y.
Usefulness of carotid duplex ultrasonography in predicting residual large-vessel occlusions after intravenous recombinant tissue plasminogen activator therapy in patients with acute ischemic stroke.
Journal of Medical Ultrasonics, 2022 in press.

Shibata S, Sakurai K, Tachikawa K, Ko R, Hino S, Fukano T, Isahaya K, Haraguchi T, Yamauchi J, Tanabe K, Nagasaka M, Hagiwara Y, Shimizu T, Akiyama H, Kobayashi Y, Hasegawa Y and Yamano Y.
The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy.
Neurology International, 14(4):981-990, 2022.
■ こちらの論文が Neurol. Int., 2022 Dec;14(4) の表紙を飾りました。
⇒詳細はこちら

Kikuchi T, Takao N, Sato T, Isahaya K, Hino S, Kaburagi M, Tachikawa K, Ko R, Shibata S, Kaburagi K, Iijima N, Mizukami H, MD, Sakurai K, Yamauchi J, Kimura A, Shimohata T, Yamano Y.
The level of CSF CXCL10 is highly elevated and decreased after steroid therapy in patients with autoimmune glial fibrillary acidic protein astrocytopathy.
Clinical and Experimental Neuroimmunology, 2022 in press.
doi: 10.1111/cen3.1273
PDFはこちら

Matsumoto H, Shiraishi M, Higashi A, Hino S, Kaburagi M, Mizukami H, Futaba M, Yamauch J, Tanabe K, Sato T, Yamano Y.
The Forward and Lateral Tilt Angle of the Neck and Trunk Measured by Three-Dimensional Gait and Motion Analysis as a
Candidate for a Severity Index in Patients with Parkinson’s Disease.
Neurology International, 14(3):727-737, 2022.
doi: 10.3390/neurolint14030061
■ こちらの論文が Neurol. Int., 2022 Sep;14(3) の表紙を飾りました。
⇒詳細はこちら

Sasaki N, Sato T, Yamatoku M, Yamano Y.
Efficacy of repetitive transcranial magnetic stimulation for gait disturbance in HTLV-1 associated myelopathy.
NeuroRehabilitation, 51(3):519-526, 2022.🆕
doi: 10.3233/NRE-220105

Tanaka Y, Sato T, Yagishita N, Yamauchi J, Araya N, Aratani S, Takahashi K, Kunitomo Y, Nagasaka M, Kanda Y, Uchimaru K, Morio T, Yamano Y.
Potential Role of HTLV-1 Tax-Specific Cytotoxic T Lymphocytes expressing a Unique T-cell Receptor to Promote Inflammation of the Central Nervous System in Myelopathy Associated with HTLV-1.
Front. Immunol, 13:993025, 2022.
doi: 10.3389/fimmu.2022.993025.

Puccioni-Sohler M, Poton A, Cabral-Castro M, Yamano Y, Taylor G, Casseb J.
Human T lymphotropic virus type 1-associated myelopathy: overview of HTLV-1/2 tests and potential biomarkers.
AIDS Research and Human Retroviruses, 2022 in press.
doi: 10.1089/AID.2022.0028

Wada Y, Sato T, Hasegawa H, Matsudaira T, Naganori N, Ariella L. G. Coler-Reilly, Tasaka T, Yamauchi S, Okagawa T, Momose H, Tanio M, Kuramitsu M, Sasaki D, Matsumoto N, Yagishita N, Yamauchi J, Araya N, Tanabe K, Yamagishi M, Nakashima M, Nakahata S, Iha H, Ogata M, Muramatsu M, Imaizumi Y, Uchimaru K, Miyazaki Y, Konnai S, Yanagihara K, Morishita K, Watanabe T, Yamano  Y & Saito M.
RAISING is a high-performance method for identifying random transgene integration sites.
Commun Biol , 5:535, 2022 Jun.
doi: 10.1038/s42003-022-03467-w

Imai T, Shinohara K, Uchino K, Okuma H, Futaba M, Hiruma K, Ariizumi Y & Yamano Y.
Paraneoplastic cerebellar degeneration with anti-Yo antibodies and an associated submandibular gland tumor: a case report.
BMC Neurol, 22(1):165, 2022 May.
doi: 10.1186/s12883-022-02684-4.

Nakajima T, Yoshifuji H, Yamano Y, Yurugi K, Miura Y, Maekawa T, Yoshida T, Handa H, Ohmura K, Mimori T, Terao C.
Co-occurrence of Relapsing Polychondritis and Autoimmune Thyroid Diseases.
Orphanet J Rare Dis, 17(1):101, 2022 May.
doi: org/10.21203/rs.3.rs-193156/v1

Kamoi K, Watanabe T, Uchimaru K, Okayama A, Kato S, Kawamata T, Kurozumi-Karube H, Horiguchi N, Zong Y, Yamano Y, Hamaguchi I, Nannya Y, Tojo A and Ohno-Matsui K.
Updates on HTLV-1 Uveitis.
Viruses, 14(4):794, 2022 Apr.
doi: org/10.3390/v14040794

Kimura M, Yamauchi J, Sato T, Yagishita N, Araya N, Aratani S, Tanabe K, Horibe E, Watanabe T, Coler-Reilly ALG, Nagasaka M, Akasu Y, Kaburagi K, Kikuchi T, Shibata S, Matsumoto H, Koseki A, Inoue S, Takata A, Yamano Y.
Health-related quality of life evaluation using the Short Form-36 in patients with human T-lymphotropic virus type 1-associated myelopathy.
Front Med , 9:879379, 2022 Apr.
doi: org/10.3389/fmed.2022.879379

Takeda H, Imoto K, Umemoto K, Doi A, Arai H, Horie Y, Mizukami T, Oguri T, Ogura T, Izawa N, Yamamoto H, Yamano Y, Sunakawa Y.
Clinical Utility of Genomic Profliling Tests in Patients with Advanced Gastrointestinal Cancers.
Target Oncol, 17(2):177-185, 2022 Mar.
doi: org/10.1007/s11523-022-00871-4

Takao N, Yamano Y.
Forefront studies on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Clinical and Experimental Neuroimmunology, 13:34-41, 2022.

Yamauchi J, Tanabe K, Sato T, Nakagawa M, Matsuura E, Tsuboi Y, Tamaki K, Sakima H, Ishihara S, Ohta Y, Matsumoto N, Kono K, Yagishita N, Araya N, Takahashi K, Kunitomo Y, Nagasaka M, Coler-Reilly A, Hasegawa Y, Araujo A, Jacobson S, Fernanda Rios Grassi M, Galvão-Castro B, Bland M, P Taylor G, Martin F, Yamano Y.
Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P).
Viruses, 14(1):136, 2022 Jan.
doi: org/10.3390/v14010136

Shimizu J, Yamano Y, Kawahata K, Suzuki N.
Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019 demonstrates reduction of airway involvement compared with that in 2009.
Sci Rep, 12(1):465, 2022 Jan.
doi: 10.1038/s41598-021-04493-0

星野俊、土橋瑶子、佐々木梨衣、大塚快信、山野嘉久.
新規診断基準が早期診断に有用であったCreutzfeldt-Jakob病4例の比較検討.
脳神経内科, 97(6):776-782, 2022.🆕

山野嘉久.
HTLV-1関連脊髄症(HAM).
CLINICAL NEUROSCIENCE, 40(11);1406-1408, 2022年11月.🆕

山野嘉久, 松田文彦.
難病プラットフォームの確立と展開.
臨床評価, 50(2):194-208, 2022年10月.🆕

山野嘉久.
難病患者へのオンライン診療の挑戦と展望.
Medical Science Digest, 48(7):16-18, 2022年7月.

鷹尾直誠, 山野嘉久.
HTLV-1関連脊髄症(HAM).
Clinical Neuroscience, 40(6):798-800, 2022年6月.

山野嘉久.
HTLV-1 associated myelopathy(HAM).
日本臨牀 増刊号 免疫性神経疾患(第2版),80(5):340-346, 2022年5月.

山野嘉久.
ウイルス感染症(レトロウイルス感染症)
内科学 第12版, V305-V307, 2022年3月.

山野嘉久.
ウイルス感染症(遅発性ウイルス感染症)
内科学 第12版, V307-V308, 2022年3月.

山野嘉久.
ウイルス感染症(その他のウイルス感染症〈狂犬病・ポリオ・帯状疱疹〉)
内科学 第12版, V308-V310, 2022年3月.

Hoshino M, Sasaki R, Tsuchihashi Y, Otsuka Y, Sakurai K, Yamano Y.
A case of autoimmune encephalitis with involuntary movements as the first symptom and suspected association with mumps virus infection.
臨床神経学,62:140-144,2022 Feb.

清水高弘, 山野嘉久.
脳内血管.
CLINICAL NEUROSCIENCE, 40(2):161-166, 2022 Feb.